Skip to main content
# Title Department Research Year
481 Novel Class of Benzimidazole-Thiazole Hybrids: The Privileged Scaffolds of Potent Anti-Inflammatory Activity with Dual Inhibition of Cyclooxygenase and 15-Lipoxygenase Enzymes Department of Pharmaceutical Organic Chemistry 2020
482 Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity Department of Pharmaceutical Organic Chemistry 2020
483 Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Department of Pharmaceutical Organic Chemistry 2020
484 Sulpiride Gastro-retentive Floating Microsponges; Analytical study, In vitro Optimization and In vivo Characterization Department of Industrial Pharmacy 2020
485 Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients 2020
486 A Hybrid In Silico/In Vitro Target Fishing Study to Mine
Novel Targets of Urolithin A and B: A Step Towards a Better
Comprehension of Their Estrogenicity
Department of Pharmaceutical Organic Chemistry 2020
487 Promising selective MAO-B inhibition by sesamin, a lignan from Zanthoxylum flavum stems 2020
488 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
489 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers Department of Pharmaceutical Analytical Chemistry 2020
490 New antimicrobial and cytotoxic benzofuran glucoside from Senecio glaucus L 2020